MEDBOX | Toolbox Diagnostics & Laboratory Guidance

Organisation Mondiale de la Santé OMS (2021) C_WHO

‎‎Orientations provisoires, 28 janvier 2021 Dans cette version mise à jour des orientations sur la sécurité biologique en laboratoire en rapport avec le SARS-CoV-2, le virus responsable de la maladie à coronavirus 2019 (COVID-19), les points suivants ont été ajoutés : aspects de sécurité biologique relatifs à la réalisation des tests diagnostiques rapides antigéniques, manipulation des nouveaux variants du SARS-CoV-2 au laboratoire, mise à jour de la décontamination des tests avant leur élimination, équipement de protection individuelle (EPI) pour le prélèvement d’échantillons et, même s’ils ne concernent pas directement la sécurité biologique, dangers chimiques et leur élimination en toute sécurité

Tags: COVID-19, laboratory biosafety, Testing, coronavirus,

Source: https://apps.who.int/iris/bitstream/hand

Comprehensive COVID-19 Slideset: Transmission and Diagnosis

Clinical Care Options (2021) CC

Slideset updated regularly to reflect the state of the COVID-19 pandemic and to include the latest data and guidance on best practices for diagnosis and prevention of transmission.

Tags: COVID-19, transmission, prevention, diagnosis, Infection Prevention and Control (IPC), physical distancing, non-pharmaceutical interventions NPI, Epidemiology,

Source: https://www.clinicaloptions.com/infectio

A Concise Quality Control Guide on Essential Drugs and other Medicines: COVID-19 Special Issue

Jähnke, R.W.O. and Kornelia Dwornik (2021) CC

Two test methods on dexamethasone tablets and injections

Tags: minilab, fake drugs, falsified drugs, Testing, laboratory, COVID-19, dexamethasone,

Source: https://www.gphf.org/images/downloads/Ma

Control Visual y Cromatografía en Capa Fina: Edición especial de COVID-19

Jähnke, R.W.O. and Kornelia Dwornik (2021) CC

Dexametasona en comprimimidos Dexametasona inyectable

Tags: minilab, fake drugs, falsified drugs, Testing, laboratory, COVID-19, dexamethasone,

Source: https://www.gphf.org/images/downloads/Ma

Tests physiques & Chromatographie sur couche mince : COVID-19 numeró spécial

Jähnke, R.W.O. and Kornelia Dwornik (2021) CC

deux méthodes d'essai sur les comprimés et les injections de dexaméthasone

Tags: minilab, fake drugs, falsified drugs, Testing, laboratory, COVID-19, dexaméthasone,

Source: https://www.gphf.org/images/downloads/Ma

Methods for the detection and identification of SARS-CoV-2 variants, March 2021

World Health Organization WHO, Regional Office of Europe (2021) C_WHO

Tags: SARS-CoV-2, variants, detection,

Source: https://apps.who.int/iris/bitstream/hand

Практическое руководство по биологической безопасности в лабораторных условиях в связи с коронавирусной инфекцией (COVID-19), Временные рекомендации28 января 2021 г.

World Health Organization WHO (2021) C_WHO

Основные аспекты обеспечения биологической безопасности в лабораторных условиях в связи с распростра��ением вируса SARS-Co

Tags: COVID-19, лаборатория, биобезопасность, оценка угроз,

Source: https://apps.who.int/iris/bitstream/hand

Laboratory biosafety guidance related to coronavirus disease (COVID-19) , Arabic Version

World Health Organization WHO (2021) C_WHO

28 January 2021. The purpose of this document is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patients.

Tags: COVID-19, laboratory, biosafety, risk assessment,

Source: https://apps.who.int/iris/bitstream/hand

Orientations sur la sécurité biologique en laboratoire en rapport avec la maladie à coronavirus 2019 (COVID-19), Orientations provisoires 28 janvier 2021

Organisation Mondiale de la Santé OMS (2021) C_WHO

28 Jan. 2021. L’objet de ce document est de fournir des orientations provisoires sur la sécurité biologique en laboratoire applicable à l’analyse d’échantillons cliniques issus de patients

Tags: COVID-19, laboratoire, bioséccurité, evaluation des risques,

Source: https://apps.who.int/iris/bitstream/hand

Organización Mundial de la Salud OMS (2021) C_WHO

The latest update (28 January 2021) includes the following addition and revision: biosafety aspects for working with antigen-detecting rapid diagnostic test; handling new variants of SARS-CoV-2 in the laboratory; updated assay decontamination before disposal; personal protective equipment (PPE) for specimen collection; addressing chemical hazards and their safe disposal; and the fourth edition of the WHO Laboratory Biosafety Manual (LBM4) is now available and the terminology in this guidance was aligned with the LBM4

Tags: COVID-19, laboratory biosafety, Testing, coronavirus,

Source: https://apps.who.int/iris/bitstream/hand

	Orientations sur la sécurité biologique en laboratoire en rapport avec la maladie à coronavirus 2019 (‎‎COVID-19) Organisation Mondiale de la Santé OMS (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX ‎‎Orientations provisoires, 28 janvier 2021 Dans cette version mise à jour des orientations sur la sécurité biologique en laboratoire en rapport avec le SARS-CoV-2, le virus responsable de la maladie à coronavirus 2019 (COVID-19), les points suivants ont été ajoutés : aspects de sécurité biologique relatifs à la réalisation des tests diagnostiques rapides antigéniques, manipulation des nouveaux variants du SARS-CoV-2 au laboratoire, mise à jour de la décontamination des tests avant leur élimination, équipement de protection individuelle (EPI) pour le prélèvement d’échantillons et, même s’ils ne concernent pas directement la sécurité biologique, dangers chimiques et leur élimination en toute sécurité Tags: COVID-19, laboratory biosafety, Testing, coronavirus, Source: https://apps.who.int/iris/bitstream/hand
	Comprehensive COVID-19 Slideset: Transmission and Diagnosis Clinical Care Options (2021) CC Open external link (7) Add to my MEDBOX Slideset updated regularly to reflect the state of the COVID-19 pandemic and to include the latest data and guidance on best practices for diagnosis and prevention of transmission. Tags: COVID-19, transmission, prevention, diagnosis, Infection Prevention and Control (IPC), physical distancing, non-pharmaceutical interventions NPI, Epidemiology, Source: https://www.clinicaloptions.com/infectio
	A Concise Quality Control Guide on Essential Drugs and other Medicines: COVID-19 Special Issue Jähnke, R.W.O. and Kornelia Dwornik (2021) CC View PDF(5) Download (3) Add to my MEDBOX Two test methods on dexamethasone tablets and injections Tags: minilab, fake drugs, falsified drugs, Testing, laboratory, COVID-19, dexamethasone, Source: https://www.gphf.org/images/downloads/Ma
	Control Visual y Cromatografía en Capa Fina: Edición especial de COVID-19 Jähnke, R.W.O. and Kornelia Dwornik (2021) CC View PDF(1) Download (1) Add to my MEDBOX Dexametasona en comprimimidos Dexametasona inyectable Tags: minilab, fake drugs, falsified drugs, Testing, laboratory, COVID-19, dexamethasone, Source: https://www.gphf.org/images/downloads/Ma
	Tests physiques & Chromatographie sur couche mince : COVID-19 numeró spécial Jähnke, R.W.O. and Kornelia Dwornik (2021) CC View PDF(1) Download (1) Add to my MEDBOX deux méthodes d'essai sur les comprimés et les injections de dexaméthasone Tags: minilab, fake drugs, falsified drugs, Testing, laboratory, COVID-19, dexaméthasone, Source: https://www.gphf.org/images/downloads/Ma
	Methods for the detection and identification of SARS-CoV-2 variants, March 2021 World Health Organization WHO, Regional Office of Europe (2021) C_WHO View PDF(1) Download (1) Add to my MEDBOX Tags: SARS-CoV-2, variants, detection, Source: https://apps.who.int/iris/bitstream/hand
	Практическое руководство по биологической безопасности в лабораторных условиях в связи с коронавирусной инфекцией (COVID-19), Временные рекомендации28 января 2021 г. World Health Organization WHO (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX Основные аспекты обеспечения биологической безопасности в лабораторных условиях в связи с распростра��ением вируса SARS-Co Tags: COVID-19, лаборатория, биобезопасность, оценка угроз, Source: https://apps.who.int/iris/bitstream/hand
	Laboratory biosafety guidance related to coronavirus disease (COVID-19) , Arabic Version World Health Organization WHO (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX 28 January 2021. The purpose of this document is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patients. Tags: COVID-19, laboratory, biosafety, risk assessment, Source: https://apps.who.int/iris/bitstream/hand
	Orientations sur la sécurité biologique en laboratoire en rapport avec la maladie à coronavirus 2019 (COVID-19), Orientations provisoires 28 janvier 2021 Organisation Mondiale de la Santé OMS (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX 28 Jan. 2021. L’objet de ce document est de fournir des orientations provisoires sur la sécurité biologique en laboratoire applicable à l’analyse d’échantillons cliniques issus de patients Tags: COVID-19, laboratoire, bioséccurité, evaluation des risques, Source: https://apps.who.int/iris/bitstream/hand
	Orientaciones sobre la bioseguridad en el laboratorio relacionada con la COVID-19 Organización Mundial de la Salud OMS (2021) C_WHO View PDF(0) Download (1) Add to my MEDBOX The latest update (28 January 2021) includes the following addition and revision: biosafety aspects for working with antigen-detecting rapid diagnostic test; handling new variants of SARS-CoV-2 in the laboratory; updated assay decontamination before disposal; personal protective equipment (PPE) for specimen collection; addressing chemical hazards and their safe disposal; and the fourth edition of the WHO Laboratory Biosafety Manual (LBM4) is now available and the terminology in this guidance was aligned with the LBM4 Tags: COVID-19, laboratory biosafety, Testing, coronavirus, Source: https://apps.who.int/iris/bitstream/hand

About MEDBOX

MEDBOX Video Series